And this is important, as I was mentioning earlier on, you know, Medicaid populations, minorities, racial and ethnic minorities are over represented in those patients
furthermore, the test for interaction did not indicate the direction of the treatment effect
Wei, Z., Liu, X., Cheng, C., Yu, W
At the moment, most people accessing the drugs pay for them out of their own pocket, as insurance in the US has traditionally not covered weight-loss therapies, but that may change in future as studies point to benefits of GLP-1 therapies in cardiovascular disease risk reduction and other obesity-related conditions like knee osteoarthritis, metabolic-associated steatohepatitis (MASH), and chronic kidney disease (CKD)
Apathy, Depression & Motivation (00:10:40) Ego Depletion & Willpower as a Limited Resource
It works by increasing insulin and decreasing glucagon after meals to control blood sugar and slowing down digestion (gastroparesis) to make you feel full sooner and eat less